Showing 1,268 results

Filters Content type: News, Editors' picks Topic: New & experimental HIV treatments

News and information about clinical trials and regulatory approval of new medications to treat HIV.

New & experimental HIV treatments

New FDA Guidance for Industry: Developing Antiretroviral Drugs for Treatment

Editor's pick
US Food and Drug Administration
11 June 2013
New & experimental HIV treatments

European Commission Approves Stribild®, a New Single Tablet Regimen for the Treatment of HIV-1 Infection

Editor's pick
Gilead press release
28 May 2013
New & experimental HIV treatments

Nanoparticles May Transport HIV Meds to the Brain

Editor's pick
AIDSMeds
16 May 2013
The search for a cure

UPDATE: Sangamo Highlights Encouraging Preliminary Anti-Viral HIV Data

Editor's pick
Benzinga
15 May 2013
New & experimental HIV treatments

Protease Inhibitors Boost Levels of Cenicriviroc, a CCR5/CCR2 Antagonist

Editor's pick
NATAP
14 May 2013
Pharmaceutical industry

Johnson & Johnson allies with biotech startup on HIV drug in China

Editor's pick
FierceBiotech
1 May 2013
New & experimental HIV treatments

FDA rejects two of the four drugs in Gilead's blockbuster HIV drug Stribild

Editor's pick
FierceBiotech
30 April 2013
The search for an HIV prevention vaccine

Researchers stop the only current HIV vaccine efficacy trial

News
26 April 2013
The search for a cure

Doctors' historic effort to cure child with HIV and leukemia

Editor's pick
MPR News
25 April 2013
New & experimental HIV treatments

New nanotechnique to deliver life-saving drugs to the brain

Editor's pick
Phys.org
22 April 2013
Generic medicines

Preparing for Generics: The push for affordable HIV treatment doesn’t end with patent expirations

Editor's pick
Treatment Action Group
11 April 2013
New & experimental HIV treatments

DFH Pharma, USA Partners with Hetero Group, INDIA to Develop 2nd Generation HIV Maturation Inhibitor Drugs

Editor's pick
DFH Pharma press release
4 April 2013
New & experimental HIV treatments

European CHMP Adopts Positive Opinion for Stribild®, a Once-Daily, Integrase Inhibitor-Based, Single Tablet Regimen for the Treatment of HIV-1 Infection

Editor's pick
Gilead press release
22 March 2013
Weight gain & lipodystrophy

Health Canada rejects tesamorelin for lipodystrophy

Editor's pick
Theratechnologies press release
13 March 2013
The search for a cure

Gene therapy studies show potential for HIV control without drugs

News
13 March 2013
Vaginal rings & topical PrEP

Bee Venom Destroys HIV And Spares Surrounding Cells

Editor's pick
HIV / AIDS News From Medical News Today
10 March 2013
People with limited treatment options

New integrase inhibitor dolutegravir helps treatment-experienced people on failing therapy

News
10 March 2013
Finance & funding

Funding Scientific Innovation: Global Investments in HIV Treatment Research and Development in 2010 and 2011

Editor's pick
Treatment Action Group
7 March 2013
New & experimental HIV treatments

Can people with resistant HIV omit NRTIs when switching from a failing regimen?

News
7 March 2013
New & experimental HIV treatments

New pro-drug tenofovir alafenamide appears equally effective but better tolerated

News
7 March 2013
New & experimental HIV treatments

New NNRTI MK-1439 shows promise in early clinical trial

News
6 March 2013
New & experimental HIV treatments

Dual CCR5/CCR2 inhibitor cenicriviroc has anti-inflammatory as well as anti-HIV effect

News
6 March 2013
Pharmaceutical industry

GSK wins priority status for new HIV drug in US

Editor's pick
Reuters
18 February 2013
How HIV works

Newly identified natural protein blocks HIV, other deadly viruses

Editor's pick
UCLA press release
12 February 2013